Esophageal cancer remains a major health threat worldwide, with considerable regional disparities in incidence and mortality. Key modifiable risk factors—smoking, alcohol consumption, and obesity—are closely linked to ...
Dec 11, 2024
0
0
A joint research team has announced that it is possible to detect and precisely remove metastatic lymph nodes during endometrial cancer surgery using neo-mannosyl human serum albumin-indocyanine green (MSA-ICG) and a laparoscopic ...
Oct 11, 2024
0
0
Precancerous changes in the cells of the esophagus, a condition called Barrett's esophagus, is a risk factor for esophageal cancer. Barrett's esophagus is caused by gastroesophageal reflux disease (GERD), which occurs when ...
Oct 3, 2024
0
1
Approximately 600 times a day, the esophagus ferries whatever is in your mouth down to your stomach. It's usually a one-way route, but sometimes acid escapes the stomach and travels back up. That can damage the cells lining ...
Sep 18, 2024
0
27
Esophageal cancer, a highly aggressive malignancy originating in the esophageal epithelium, poses significant public health challenges in China, where it ranks sixth in incidence and fifth in mortality among cancers. The ...
Aug 20, 2024
0
0
A novel test developed by Johns Hopkins Kimmel Cancer Center investigators could give gastroenterologists insight into which patients with Barrett's esophagus—a premalignant condition in which parts of the esophagus become ...
Aug 15, 2024
0
20
Artificial intelligence is being used in a wide variety of applications in medicine, and now scientists have developed an AI system that can boost detection rates for cancerous and precancerous lesions of the esophagus, which ...
A research team led by Prof. Chu Yannan from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences adopted a methionine regulation strategy and found that esophageal cancer cells can be identified by ...
Jul 30, 2024
0
0
Findings from a small, proof-of-concept clinical trial have suggested that fecal microbiota transplants (FMTs) can boost the effectiveness of immunotherapy in a range of gastrointestinal cancers.
Jul 25, 2024
1
16
A team of researchers from Henan University of Science and Technology have introduced a novel method for improving drug testing for esophageal cancer (EC) using advanced three-dimensional (3D) cell culture technology. The ...
Jul 22, 2024
0
0
Esophageal cancer (or oesophageal cancer) is malignancy of the esophagus. There are various subtypes, primarily squamous cell cancer (approx 90-95% of all esophageal cancer worldwide) and adenocarcinoma (approx. 50-80% of all esophageal cancer in the United States). Squamous cell cancer arises from the cells that line the upper part of the esophagus. Adenocarcinoma arises from glandular cells that are present at the junction of the esophagus and stomach.
Esophageal tumors usually lead to dysphagia (difficulty swallowing), pain and other symptoms, and are diagnosed with biopsy. Small and localized tumors are treated surgically with curative intent. Larger tumors tend not to be operable and hence are treated with palliative care; their growth can still be delayed with chemotherapy, radiotherapy or a combination of the two. In some cases chemo- and radiotherapy can render these larger tumors operable. Prognosis depends on the extent of the disease and other medical problems, but is fairly poor.
This text uses material from Wikipedia licensed under CC BY-SA
